Overall AMGN gets a technical rating of 0 out of 10. AMGN scores bad on all fronts: it is a bad performer in the overall market and both the medium and short term pictures are negative.
The short term trend is neutral, while the long term trend is still negative. We need to see a little more continued positive action to make this really interesting.
When comparing the yearly performance of all stocks, AMGN is a bad performer in the overall market: 62% of all stocks are doing better.
AMGN is one of the better performing stocks in the Biotechnology industry, it outperforms 74% of 567 stocks in the same industry.
In the last month AMGN has a been trading in the 267.40 - 312.11 range, which is quite wide. It is currently trading in the middle of this range where prices have been consolidating recently, this may present a good entry opportunity, but some resistance may be present above.
AMGN has an average volume of 3186320 traded shares per day. This is a good sign as it is always nice to have a liquid stock.
AMGN is currently trading in the middle of its 52 week range. This is in line with the S&P500 Index, which is also trading in the middle of its range.